From: Rosalie Wyonch To: Canadians concerned about cannabis Date: July 3, 2019 Subject: Legal Cannabis and the Black Market Cannabis has been legal in Canada for almost nine months, but there is still a long way to go before the legal market reaches its full potential. The government recently released the regulations for cannabis concentrates and edible products […]
To: Canadians concerned about healthcare From: William B.P. Robson and Rosalie Wyonch Date: June 17, 2019 Re: Hoskins Pharmacare Report: Enthusiasm for Drugs Can Impair Memory The Advisory Council on the Implementation of National Pharmacare released its final report last week. It recommends implementing a universal pharmacare program for all Canadians and that the federal government cover all […]
Are there better options for getting Canadians the medications they need? Our health policy expert, Rosalie Wyonch, sits down with Michael to discuss the report released by Dr. Eric Hoskins calling for Ottawa to create a national pharmacare plan. Read the full report
From: Rosalie Wyonch To: Canadian concerned about pharmacare Date: June 11, 2019 Subject: Quebec’s Pharmacare Didn’t Break the Bank One option for achieving universal prescription drug insurance coverage would see each province include drugs alongside doctors and hospital bills in the existing medicare system. In my new C.D. Howe Institute paper, I evaluate various options for implementing universal pharmacare […]
Universal pharmacare coverage for Canadians is within reach, based on cost estimates in a new C.D. Howe Institute study. In “Filling the Gaps: A Prescription for Universal Pharmacare,” authors Rosalie Wyonch and William Robson find there are ways to close the gaps in prescription drug coverage and protect households from excessive costs when in acute need through the […]
From: Rosalie Wyonch To: Canada’s Pharmaceutical Price-Setters Date: June 3, 2019 Subject: Drug Prices: Talking Beyond the Talking Points Drug prices and whether they are too high, too low, or just right is currently a hotly debated topic in Canada. On one hand, governments and consumers assert that drug costs are growing unsustainably. On the other hand, patenting pharmaceutical […]
To: Canadians concerned about healthcare From: Rosalie Wyonch Date: May 14, 2019 Re: The Fallacy of Federal Advantage in Delivering Pharmacare One popular argument in favour of a national approach to pharmacare is that a strong federal role could lower total expenditures on drugs in Canada. The savings could occur through two channels. First, the […]
From: Michael J. Trebilcock and Kanksha Mahadevia Ghimire To: Canadian health regulators Date: May 9, 2019 Subject: Alternatives for alternative medicines In many Western countries, the use of complementary and alternative medicines (CAMs) has been growing. Individuals often use CAMs in conjunction with biomedicine (also referred to as allopathic or Western medicine), or sometimes choose to rely on CAMs […]
To: Canadians concerned about healthcare From: William B.P. Robson Date: May 2, 2019 Re: Budget Peril Lurks in Revised Health Spending Numbers Government spending on health has tended to grow faster than Canada’s economy, raising concerns about the sustainability of our healthcare system. Preliminary estimates of provincial and territorial government spending in the Canadian Institute for Health Information’s annual […]
Growth in healthcare spending by provinces and territories has been accelerating over the last four years as governments continue to overshoot their budget targets, says a report from the C.D. Howe Institute. In “Healthcare Spending Overshoots a Threat to Sustainability,” author William B.P. Robson warns that, while governments are typically budgeting growth in healthcare budgets […]
Alternative medicines need risk-based regulation according to a newly released report from the C.D. Howe Institute. In “Regulating Alternative Medicines: Disorder in the Borderlands” authors Michael J. Trebilcock and Kanksha Mahadevia Ghimire recommend regulating certain popular forms of alternative medicine, especially when their use could be life-threatening to patients.
From: Rosalie Wyonch To: Canadians concerned about pharmacare Date: April 9, 2019 Re: Assessing the National Pharmacare Report Earlier this month, the Advisory Council on the Implementation of National Pharmacare released its interim report with some core principles and foundational elements for a new system. Among the recommendations: create a national drug agency; develop a comprehensive, evidence-based national formulary; and […]
Membership Application
Interested in becoming a Member of the C.D. Howe Institute? Please fill out the application form below and our team will be in touch with next steps. Note that Membership is subject to approval.
"*" indicates required fields
Member Login
Not a Member yet? Visit our Membership page to learn more and apply.